A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab - Concepedia

Concepedia

Publication | Open Access

A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab

DOI Full Paper Access

28

Citations

20

References

2018

Year

Sang Gyu Lee, Yong‐Hee Cho, Pu-Hyeon Cha, Jeong-Soo Yoon, Eun Ji Ro, Woo-Jeong Jeong, Jieun Park, Hyuntae Kim, Tae Il Kim, Do Sik Min,

Experimental & Molecular Medicine

References

	Year	Citations

Page 1